Case series of low dose rituximab for membranous nephropathy; a single centre experience

Introduction: Rituximab is the recent treatment of choice for primary membranous nephropathy However, dose of rituximab mentioned in literature is high and not economical in middle income countries. Low dose rituximab based on CD 19 cell count can be tried as an alternative for high dose rituximab f...

Full description

Saved in:
Bibliographic Details
Main Authors: Gerry George Mathew (Author), Jayaprakash Varadharajan (Author), Sreedhar Sailapathy (Author)
Format: Book
Published: Society of Diabetic Nephropathy Prevention, 2023-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available